MedPath

Tagi Pharma, Inc.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

18

FDA:18

Drug Approvals

Ursodiol

Approval Date
Dec 18, 2023
FDA

Methazolamide

Approval Date
Mar 23, 2023
FDA

Chlorthalidone

Approval Date
Jun 22, 2022
FDA

Benzonatate

Approval Date
Jun 20, 2022
FDA

Levetiracetam

Approval Date
Dec 17, 2021
FDA

Phentolamine Mesylate

Approval Date
Dec 17, 2021
FDA

Azithromycin dihydrate

Approval Date
Nov 9, 2021
FDA

Gabapentin

Approval Date
Sep 1, 2021
FDA

Cholestyramine

Approval Date
May 12, 2021
FDA

Cholestyramine Light

Approval Date
Apr 29, 2021
FDA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.